ReGen Theranostics Overview

  • Founded
  • 2010

  • Status
  • Private

  • Employees
  • 8

  • Latest Deal Type
  • 2ndary - Private

ReGen Theranostics General Information


Provider of biotechnology services intended to research and develop stem cells. The company's service is used by the researchers to produce patient-specific iPS cell lines for the research community on a fee-for-service basis, enabling researchers to recruit patients to biopsy and convert it into cryopreserved iPSC's.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Formerly VC-backed
Primary Industry
Other Industries
Other Healthcare Services
Drug Delivery
Primary Office
  • 3033 41st Street North West
  • Suite 200
  • Rochester, MN 55901
  • United States

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

ReGen Theranostics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Secondary Transaction - Private 01-Apr-2021 00000 Completed Generating Revenue
3. Debt - General 01-Sep-2015 00000 00000 Completed Startup
2. Debt - General 01-Aug-2010 $50K $50K Completed Startup
1. Early Stage VC Completed Startup
To view ReGen Theranostics’s complete valuation and funding history, request access »

ReGen Theranostics Executive Team (2)

Name Title Board Seat Contact Info
Matt Nelson Co-Founder, Key Principal, Chief Executive Officer & President
Tim Nelson Ph.D Co-Founder
To view ReGen Theranostics’s complete executive team members history, request access »

ReGen Theranostics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial